Xcovery Holdings, Inc.
Current Promotions
No video available
Get in Touch
About
Xcovery is a biopharmaceutical company with the aim to improve the lives of cancer patients by discovering and developing innovative medicines to fight advanced tumors. We are working on a pipeline of oncology therapies to target a wide range of malignant diseases.
Our lead product, ensartinib (X-396), is a small molecule that inhibits anaplastic lymphoma kinase (ALK). Ensartinib is being investigated for the treatment of ALK positive non-small cell lung cancer. We are currently enrolling patients in our phase 2 and phase 3 clinical studies. Xcovery.com
Keywords
oncology, alk positive lung cancer, lung cancer, clinical trials, alk nsclc, kinase inhibitors, oncology research, biopharmaceutics, pharmaceutics, cancer, alk inhibitor, ensartinib, cancer research, pharma, biopharma, clinical studies, research, investigational agents, cancer therapy, hematology, clinical research
Amenities
No amenities listed yet
Upcoming Events
No upcoming events scheduled
Frequently Asked Questions
No FAQs available for this business.
Reviews
No reviews yet. Be the first to review!
Social Links
Photo Gallery
No photos available
Contact Information
Business Info
Location
Business Hours
Business hours not available
Own This Business?
Unclaimed
Take control of your business page to update information, respond to reviews, and more.
Claim This Business